Exploitation of Unconventional CD8 T-Cell Responses Induced by Engineered Cytomegaloviruses for the Development of an HIV-1 Vaccine. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/vaccines13010072
PubMed Identifier: 39852851
Publication URI: http://europepmc.org/abstract/MED/39852851
Type: Journal Article/Review
Volume: 13
Parent Publication: Vaccines
Issue: 1
ISSN: 2076-393X